Initial Treatment for Spongiotic Dermatitis

Understanding Spongiotic Dermatitis Treatment

The initial treatment for spongiotic dermatitis is topical corticosteroids of appropriate potency, which are the mainstay of treatment and can be used safely if certain precautions are taken 1

The American Academy of Dermatology recommends using the least potent preparation required to control the dermatitis 1
For adults with non-facial, non-intertriginous areas, start with class 2-5 (moderate to high potency) corticosteroids for up to 4 weeks 3
For facial, intertriginous areas or in children, use lower potency corticosteroids to minimize adverse effects 3
Apply topical corticosteroids no more than twice daily; some newer preparations require only once daily application 4
The British Journal of Dermatology suggests considering PUVA therapy for chronic cases of hand and foot involvement 5
The British Journal of Dermatology recommends considering oral alitretinoin for severe chronic hand eczema 5

Consider antihistamines for short-term use during relapses with severe pruritus 1
Non-sedating antihistamines have little value; sedating antihistamines may be more beneficial 1
If bacterial infection is present, consider appropriate antibiotics 1
For herpes simplex infection, consider oral acyclovir early in the course 4

Consider vitamin D analogues (calcipotriene, calcitriol) for chronic or recalcitrant cases 2
Consider combination therapy with topical corticosteroids and vitamin D analogues for enhanced efficacy 2
Consider topical tacrolimus where topical steroids are unsuitable or ineffective 5

Demonstrate proper application of topical preparations and provide written information to reinforce discussed issues 1
Explain the benefits and risks of topical corticosteroids to address steroid phobia 1
Assess response after 2-4 weeks and consider referral to a dermatologist if no improvement 3
Identify and avoid irritants and allergens, and wear cotton clothing rather than irritant materials like wool 1

Undertreatment due to steroid phobia is common and can lead to prolonged disease and patient suffering 1
Overuse of potent steroids on sensitive areas can lead to skin atrophy and other adverse effects 3
Failure to address secondary infection can result in treatment resistance 1
Prolonged use of topical corticosteroids without periodic assessment may lead to tachyphylaxis and adverse effects 1
Neglecting emollient therapy as an essential component of treatment 1